Wakabayashi Hiroshi

Affiliation and department：

Research field (1)： Radiology

Research theme for competitive and other funds (16)：

2022 - 2026 細胞内レドックス制御を司るがん幹細胞治療の標的トランスポーター画像診断薬の開発
2023 - 2026 標的アイソトープ治療の個別化に向けた新規被ばく線量予測システムの開発
2020 - 2023 Establishment of a method for predicting bone marrow suppression after I-131 MIBG treatment using flow cytometry
2022 - 2023 高リスク群神経芽腫に対するI-131 MIBG内照射療法:医師主導治験の推進
2019 - 2022 Development of new therapeutoc strategy for high-risk chemotherapy-refractory neuroblastoma

Show all

Papers (169)：

Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Kotaro Yoshida, Tomo Hiromasa, Seigo Kinuya. Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma. Scientific Reports. 2024. 14. 1
Kenichi Nakajima, Takeshi Matsumura, Junji Komatsu, Hiroshi Wakabayashi, Kenjiro Ono, Seigo Kinuya. Sympathetic 123I-metaiodobenzylguanidine index for Lewy body disease: probability-based diagnosis and identifying patients exempt from late imaging. Annals of Nuclear Medicine. 2024. 38. 10. 814-824
Shintaro Saito, Kenichi Nakajima, Junji Komatsu, Takayuki Shibutani, Hiroshi Wakabayashi, Hiroshi Mori, Aki Takata, Kenjiro Ono, Seigo Kinuya. Absolute quantitation of sympathetic nerve activity using [123I] metaiodobenzylguanidine SPECT-CT in neurology. EJNMMI Reports. 2024. 8. 1
Anri Inaki, Atsushi Mizokami, Hiroshi Wakabayashi, Kouji Izumi, Yoshifumi Kadono, Tadashi Toyama, Shizuko Takahara, Toshinori Murayama, Seigo Kinuya. Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer. Annals of nuclear medicine. 2024
Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya, Kazuma Ogawa. Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor. European journal of nuclear medicine and molecular imaging. 2024

ｍore...

MISC (316)：

若林大志, 赤谷憲一. 【2024年の核医学TOPICS!】甲状腺癌を考える放射線治療抵抗性甲状腺癌と再分化療法. Rad Fan. 2023. 22. 1. 26-28
若林大志, 張雪, 萱野大樹, 絹谷清剛. 難治性褐色細胞腫,傍神経節腫に対する131I-metaiodobenzyl-guanidine治療. 糖尿病・内分泌代謝科. 2023. 56. 5. 669-676
森博史, 廣正智, 若林大志, 萱野大樹, 絹谷清剛. 金沢大学附属病院におけるLu-177 DOTATATEを用いたPRRTの実際. 日本内分泌外科学会雑誌. 2023. 40. Suppl.1. S211-S211
若林大志, 張雪, 萱野大樹, 絹谷清剛. 難治性褐色細胞腫,傍神経節腫に対する131I-metaiodobenzyl-guanidine治療. 糖尿病・内分泌代謝科. 2023. 56. 5. 669-676
森博史, 廣正智, 若林大志, 萱野大樹, 絹谷清剛. 金沢大学附属病院におけるLu-177 DOTATATEを用いたPRRTの実際. 日本内分泌外科学会雑誌. 2023. 40. Suppl.1. S211-S211

ｍore...

Work history (1)：

2022/07 - 現在金沢大学附属病院核医学診療科講師

Awards (4)：

2023/11 - 日本核医学会日本核医学会リターニー奨励賞
2023/04 - 令和4年度金沢大学附属病院臨床研究優秀論文賞
2022/06 - 認定NPO法人ゴールドリボン・ネットワーク 2022年度ゴールドリボン研究助成金
2020/04 - 令和元年度金沢大学附属病院臨床研究優秀論文賞

Association Membership(s) (5)：

European association of Nuclear Medicine , JAPANESE SOCIETY OF NUCLEAR MEDICINE , JAPAN RADIOLOGICAL SOCIETY , The japanese Society of Nuclear Cardiology , The Japanese Circulation Society

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page